Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lusher

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Transfusion|January 1, 1996
The National Hemophilia Foundation provides a model of a national blood monitoring systemJ Lusher, C M Kessler, S E Bajardi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 3, 2013
Therapeutic and prophylactic ethanol lock therapy in patients with bleeding disordersM Rajpurkar, E McGrath, J Joyce, et al.
Lancet (London, England)|August 21, 1993
Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIIIJ Addiego, C Kasper, C Abildgaard, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 21, 2011
On-demand treatment of bleeds in haemophilia patients with inhibitors: strategies for securing and maintaining predictable efficacy with recombinant activated factor VIIB Sørensen, Y Dargaud, G Kenet, et al.
Drug Discovery Today|December 24, 2013
Data-driven medicinal chemistry in the era of big dataScott J Lusher, Ross McGuire, René C van Schaik, et al.
Lancet (London, England)|November 11, 1995
Transmission of hepatitis C virus by monoclonal-purified viral-attenuated factor VIII concentrateC Kessler, J Lusher, G F Pierce, et al.
Journal of Thrombosis and Haemostasis : JTH|April 23, 2004
Human recombinant DNA-derived antihemophilic factor in the treatment of previously untreated patients with hemophilia A: final report on a hallmark clinical investigationJ Lusher, C Abildgaard, S Arkin, et al.
Drug Discovery Today|May 25, 2011
A molecular informatics view on best practice in multi-parameter compound optimizationScott J Lusher, Ross McGuire, Rita Azevedo, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 30, 2014
Thromboelastography identifies children with rare bleeding disorders and predicts bleeding phenotypeA N Zia, M Chitlur, M Rajpurkar, et al.
Blood|February 1, 1997
Nephrotic syndrome as a complication of immune tolerance in hemophilia BB M Ewenstein, C Takemoto, I Warrier, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Transfusion|January 1, 1996
The National Hemophilia Foundation provides a model of a national blood monitoring systemJ Lusher, C M Kessler, S E Bajardi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 3, 2013
Therapeutic and prophylactic ethanol lock therapy in patients with bleeding disordersM Rajpurkar, E McGrath, J Joyce, et al.
Lancet (London, England)|August 21, 1993
Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIIIJ Addiego, C Kasper, C Abildgaard, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 21, 2011
On-demand treatment of bleeds in haemophilia patients with inhibitors: strategies for securing and maintaining predictable efficacy with recombinant activated factor VIIB Sørensen, Y Dargaud, G Kenet, et al.
Drug Discovery Today|December 24, 2013
Data-driven medicinal chemistry in the era of big dataScott J Lusher, Ross McGuire, René C van Schaik, et al.
Lancet (London, England)|November 11, 1995
Transmission of hepatitis C virus by monoclonal-purified viral-attenuated factor VIII concentrateC Kessler, J Lusher, G F Pierce, et al.
Journal of Thrombosis and Haemostasis : JTH|April 23, 2004
Human recombinant DNA-derived antihemophilic factor in the treatment of previously untreated patients with hemophilia A: final report on a hallmark clinical investigationJ Lusher, C Abildgaard, S Arkin, et al.
Drug Discovery Today|May 25, 2011
A molecular informatics view on best practice in multi-parameter compound optimizationScott J Lusher, Ross McGuire, Rita Azevedo, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 30, 2014
Thromboelastography identifies children with rare bleeding disorders and predicts bleeding phenotypeA N Zia, M Chitlur, M Rajpurkar, et al.
Blood|February 1, 1997
Nephrotic syndrome as a complication of immune tolerance in hemophilia BB M Ewenstein, C Takemoto, I Warrier, et al.
Pageof 5